» Articles » PMID: 33996823

BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis

Overview
Specialty Cell Biology
Date 2021 May 17
PMID 33996823
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Meiosis is a specialized cell cycle that results in the production of haploid gametes for sexual reproduction. During meiosis, homologous chromosomes are connected by chiasmata, the physical manifestation of crossovers. Crossovers are formed by the repair of intentionally induced double strand breaks by homologous recombination and facilitate chromosome alignment on the meiotic spindle and proper chromosome segregation. While it is well established that the tumor suppressors BRCA1 and BRCA2 function in DNA repair and homologous recombination in somatic cells, the functions of BRCA1 and BRCA2 in meiosis have received less attention. Recent studies in both mice and the nematode have provided insight into the roles of these tumor suppressors in a number of meiotic processes, revealing both conserved and organism-specific functions. BRCA1 forms an E3 ubiquitin ligase as a heterodimer with BARD1 and appears to have regulatory roles in a number of key meiotic processes. BRCA2 is a very large protein that plays an intimate role in homologous recombination. As women with no indication of cancer but carrying BRCA mutations show decreased ovarian reserve and accumulated oocyte DNA damage, studies in these systems may provide insight into why BRCA mutations impact reproductive success in addition to their established roles in cancer.

Citing Articles

Mitochondria: the epigenetic regulators of ovarian aging and longevity.

Mani S, Srivastava V, Shandilya C, Kaushik A, Singh K Front Endocrinol (Lausanne). 2024; 15:1424826.

PMID: 39605943 PMC: 11598335. DOI: 10.3389/fendo.2024.1424826.


Benign polymorphisms in the BRCA genes with linkage disequilibrium is associated with cancer characteristics.

Lee K, Chen D, Loh Z, Chung W, Wang C, Chen P Cancer Sci. 2024; 115(12):3973-3985.

PMID: 39394900 PMC: 11611775. DOI: 10.1111/cas.16364.


The Reproductive Lifespan of Ovarian Follicle.

Kalinderi K, Kalinderis M, Papaliagkas V, Fidani L Reprod Sci. 2024; 31(9):2604-2614.

PMID: 38816594 DOI: 10.1007/s43032-024-01606-8.


BRCA1 and Its Vulnerable C-Terminal BRCT Domain: Structure, Function, Genetic Mutations and Links to Diagnosis and Treatment of Breast and Ovarian Cancer.

Ismail T, Alzneika S, Riguene E, Al-Maraghi S, Alabdulrazzak A, Al-Khal N Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543119 PMC: 10974778. DOI: 10.3390/ph17030333.


Ovarian aging: mechanisms and intervention strategies.

Zhu Z, Xu W, Liu L Med Rev (2021). 2023; 2(6):590-610.

PMID: 37724254 PMC: 10471094. DOI: 10.1515/mr-2022-0031.


References
1.
Hill S, Rolland T, Adelmant G, Xia X, Owen M, Dricot A . Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage. Genes Dev. 2014; 28(17):1957-75. PMC: 4197947. DOI: 10.1101/gad.241620.114. View

2.
Hakem R, de la Pompa J, Sirard C, Mo R, Woo M, Hakem A . The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell. 1996; 85(7):1009-23. DOI: 10.1016/s0092-8674(00)81302-1. View

3.
Kowalczykowski S . An Overview of the Molecular Mechanisms of Recombinational DNA Repair. Cold Spring Harb Perspect Biol. 2015; 7(11). PMC: 4632670. DOI: 10.1101/cshperspect.a016410. View

4.
Yokoo R, Zawadzki K, Nabeshima K, Drake M, Arur S, Villeneuve A . COSA-1 reveals robust homeostasis and separable licensing and reinforcement steps governing meiotic crossovers. Cell. 2012; 149(1):75-87. PMC: 3339199. DOI: 10.1016/j.cell.2012.01.052. View

5.
Hartley C, McCulloch R . Trypanosoma brucei BRCA2 acts in antigenic variation and has undergone a recent expansion in BRC repeat number that is important during homologous recombination. Mol Microbiol. 2008; 68(5):1237-51. PMC: 2408642. DOI: 10.1111/j.1365-2958.2008.06230.x. View